Gemifloxacin Mesylate is used for treating various bacterial infections. It was first introduced by Lg Chem Ltd in its drug Factive on Apr 4, 2003. 2 different companies have introduced drugs containing Gemifloxacin Mesylate.

Gemifloxacin Mesylate Patents

Given below is the list of patents protecting Gemifloxacin Mesylate, along with the drug name that holds that patent and the company name owning that drug.

Download patent list as spreadsheet

Get the complete list right in your inbox!

Drug Used in	Drug Patent Number	Drug Patent Title	Drug Patent Expiry	Drug Owner
Factive	US6262071	Methods of use of antimicrobial compounds against pathogenic amycoplasma bacteria	Sep 21, 2019 (Expired)	Lg Chem Ltd
Factive	US6331550	Methods of use of quinolone compounds against anaerobic pathogenic bacteria	Sep 21, 2019 (Expired)	Lg Chem Ltd
Factive	US6455540	Methods of use of quinolone compounds against anaerobic pathogenic bacteria	Sep 21, 2019 (Expired)	Lg Chem Ltd
Factive	US6803376	Method of use of quinolone compounds against pneumococcal and haemophilus bacteria	Sep 21, 2019 (Expired)	Lg Chem Ltd
Factive	US6340689	Methods of use of quinolone compounds against atypical upper respiratory pathogenic bacteria	Sep 14, 2019 (Expired)	Lg Chem Ltd
Factive	US6723734	Salt of naphthyridine carboxylic acid derivative	Mar 20, 2018 (Expired)	Lg Chem Ltd
Factive	US5776944	7-(4-aminomethyl-3-methyloxyiminopyrroplidin-1-yl)-1-cyclopropyl-6-flu oro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid and the process for the preparation thereof	Apr 04, 2017 (Expired)	Lg Chem Ltd
Factive	US5633262	Quinoline carboxylic acid derivatives having 7-(4-amino-methyl-3-oxime) pyrrolidine substituent and processes for preparing thereof	Jun 15, 2015 (Expired)	Lg Chem Ltd
Factive	US5962468	7-(4-aminomethyl-3-methyloxyiminopyrrolidin-1-yl)-1- cyclopropyl-6-fluoro-4-oxo-1, 4-dihydro-1, 8-naphthyridine-3-carboxylic acid and the process for the preparation thereof	Jun 15, 2015 (Expired)	Lg Chem Ltd

Add above patents to watchlist

Gemifloxacin Mesylate's Family Patents

Unlock Global Patents

Gemifloxacin Mesylate Generic API Manufacturers

Only one generic application has been filed for Gemifloxacin Mesylate.

Given below is the list of companies who have filed for Gemifloxacin Mesylate generic, along with the locations of their manufacturing plants worldwide.